Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

XGN

+ Watchlist+ Portfolio

Exagen Inc.

Regulated industryPhysical productsSells to businessesTags from an AI model reading the company description.
GridBrain

GridBrain — Sign in

GridSentinel

GridSentinel — Sign in

GridAegis

GridAegis — Sign in

Key Metrics

Previous Close
$3.76
52-Week Range
$2.59 – $9.22
Market Cap
$99.50M
P/E (TTM)
—
EPS (TTM)
-0.76
Dividend Yield
0.00%
Advanced Metrics
Price/Book
7.20
PEG Ratio
—
Return on Equity
-113.88%
Return on Assets
-14.74%
Gross Margin
58.74%
Operating Margin
-19.27%
Profit Margin
-25.14%
Current Ratio
3.46
Debt/Equity
2.09
Total Debt
$28.76M
Free Cash Flow
$-5.71M
Revenue Growth
6.80%
Earnings Growth
—
Enterprise Value
$100.17M

Market Snapshot

About

Exagen is a commercial-stage diagnostics company focused on transforming the care continuum for patients with autoimmune diseases. The company has developed and commercialized a portfolio of innovative testing products that enable differential diagnosis and monitor disease activity in rheumatic and autoimmune diseases. Exagen specializes in cell-bound complement activation products and other biomarker-based tests.